drugset
drugset / Trial / NCT03553316

Drug-Drug Interaction Between PK101-001 and PK101-002

NCT03553316 ↗

Phase 1 Completed 49 enrolled PMG Pharm Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

To evaluate the drug-drug interaction of PK101-001 and PK101-002 in healthy volunteers.

Timeline

Start
2019-02-28
Primary completion
2019-03-22
Completion
2019-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject PK101-001 Unknown — —
Subject PK101-002 Unknown — —

Indications

arthritic joint disease